Palasis Maria 4

What Happened
Maria Palasis, a director of Beta Bionics, was granted 16,965 restricted stock units (RSUs) on May 21, 2026. The Form 4 reports the acquisition at $0.00 per share (code A — award/grant), reflecting a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-21 (Form 4 filed 2026-05-26). Filing was submitted one business day after the 2-business-day SEC deadline.
• Security/amount: 16,965 shares reported as acquired (restricted stock units) at $0.00 per share.
• Transaction code: A (award/grant).
• Shares owned after transaction: Not stated in the filing.
• Footnote: F1 — represents a restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

Context
RSU grants to directors are common as compensation and typically vest over time; the filing does not specify a vesting schedule or whether any shares were immediately transferable. Because this is an award (not a market purchase), it should be viewed as compensation disclosure rather than a direct bullish or bearish trading signal.